Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4880PDF: 4001HTML: 385 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
4067PDF: 1630HTML: 369 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4769PDF: 1844HTML: 1451 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2820PDF: 977HTML: 2151 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3903PDF: 2691HTML: 1732 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2539PDF: 1966HTML: 1098 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4280PDF: 1266HTML: 2140Fig.1: 256Fig. 2: 152Table 1: 266Table2: 295Table 3: 288 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3984PDF: 1761HTML: 123 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
5035PDF: 1660HTML: 2291Untitled: 295Untitled: 313Untitled: 334Untitled: 287Untitled: 296 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1608PDF: 913HTML: 3158 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3794PDF: 1829HTML: 5995Fig1-Ag-Pil: 302Ag-Pil Fig.2: 297 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1492PDF: 516HTML: 18651Figure 1: 221Figure 2: 204Figure 3: 225Figure 4: 269Figure 5: 228 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1704HTML: 436PDF: 1051Suppl. Files: 540 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1495PDF: 596HTML: 316 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2786PDF: 1777HTML: 2478Table1: 321 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2203PDF: 1006HTML: 1120 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3465PDF: 1151HTML: 2611 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
2161PDF: 895HTML: 693 -
-
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3352PDF: 984HTML: 7329Kost Fig1: 252Kost Fig 2: 231Kost Fig3: 252Kost Fig 4: 268Kost Fig5: 255Kost fig 6: 251 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2554PDF: 1430HTML: 17257Bassan Fig.1: 192Bassan Fig.2: 298Bassan Fig.4: 182Fig.3: 333 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1823PDF: 1184HTML: 532 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1915PDF: 1114HTML: 1900Tables: 243 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1280PDF: 607HTML: 413 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1530PDF: 673HTML: 4208 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4533PDF: 2073HTML: 5581Table 1: 331 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3660PDF: 908HTML: 3046Figure 1a and 1b: 230Figure 2: 247Figure 3: 233Figure 4: 225Figure 5: 225Tables 1-5: 201 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6038PDF: 1643HTML: 1690Untitled: 302 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1738PDF: 899HTML: 2224Untitled: 292Untitled: 263Untitled: 250Untitled: 288Untitled: 278 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1805PDF: 837HTML: 1526 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
2100PDF: 762HTML: 2470Untitled: 224Figure 1 a: 230Figure 1 b: 229Fig 1 c: 211Figure 1 d: 282 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
2236PDF: 516HTML: 263







